The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Mirum Pharmaceuticals Inc shares valued at $155,091 were sold by Fairey William on Jun 11 ’25. At $48.42 per share, Fairey William sold 3,203 shares. The insider’s holdings dropped to 2,500 shares worth approximately $0.13 million following the completion of this transaction.
Also, WILLIAM C FAIREY purchased 3,203 shares, netting a total of over 155,091 in proceeds.
Before that, Ramasastry Saira had sold 5,703 shares from its account. In a trade valued at $263,492, the Director traded Mirum Pharmaceuticals Inc shares for $46.20 each. Upon closing the transaction, the insider’s holdings decreased to 5,703 shares, worth approximately $0.0.
Analysts at Stifel started covering the stock with ‘”a Buy”‘ outlook in a report released in mid April. As of December 18, 2023, H.C. Wainwright has reiterated its “Buy” rating for MIRM.
Analyzing MIRM Stock Performance
On last trading session,, Mirum Pharmaceuticals Inc [NASDAQ: MIRM] rose 0.20% to $50.80. The stock’s lowest price that day was $49.91, but it reached a high of $51.0675 in the same session. During the last five days, there has been a surge of approximately 4.83%. Over the course of the year, Mirum Pharmaceuticals Inc shares have jumped approximately 22.85%. Shares of the company reached a 52-week high of $54.23 on 02/21/25 and a 52-week low of $36.88 on 04/09/25.
Support And Resistance Levels for Mirum Pharmaceuticals Inc (MIRM)
According to the 24-hour chart, there is a support level at 50.12, which, if violated, would cause prices to drop to 49.43. In the upper region, resistance lies at 51.28. The next price resistance is at 51.75. RSI (Relative Strength Index) is 73.39 on the 14-day chart, showing overbought technical sentiment.
Is Mirum Pharmaceuticals Inc subject to short interest?
Stocks of Mirum Pharmaceuticals Inc saw a sharp steep in short interest on 2025-05-30 dropping by -0.17 million shares to 6.06 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 6.23 million shares. A decline of -2.74% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 15.27 of the overall float, the days-to-cover ratio (short ratio) decline to 15.27.
Which companies own the most shares of Mirum Pharmaceuticals Inc (MIRM)?
In terms of Mirum Pharmaceuticals Inc share price expectations, FactSet research, analysts set an average price target of 59.5 in the next 12 months, up nearly 17.36% from the previous closing price of $50.70. Analysts anticipate Mirum Pharmaceuticals Inc stock to reach 75 by 2025, with the lowest price target being 39. In spite of this, 9 analysts ranked Mirum Pharmaceuticals Inc stock as Buy at the end of 2025. On November 13, 2023, Morgan Stanley assigned a price target of “an Overweight” to the stock and initiated coverage with a $60.
